United States Diabetes Care Drugs and Devices Market Report by Offering (Devices, Drugs), Distribution Channel (Online, Offline), and Region 2025-2033

United States Diabetes Care Drugs and Devices Market Report by Offering (Devices, Drugs), Distribution Channel (Online, Offline), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A25475

United States Diabetes Care Drugs and Devices Market Overview:

The United States diabetes care drugs and devices market size reached USD 54.84 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 89.76 Billion by 2033, exhibiting a growth rate (CAGR) of 5.63% during 2025-2033. The market is propelled by rising prevalence of diabetes, rising healthcare spending of the population, various technological advancements, increasing awareness and education among patients, and government policies and reimbursement programs.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 54.84 Billion
Market Forecast in 2033 USD 89.76 Billion
Market Growth Rate 2025-2033 5.63%


United States Diabetes Care Drugs and Devices Market Trends:

Increasing Prevalence of Diabetes

The rising prevalence of diabetes in the United States is a major factor driving the market for diabetes care medications and devices. As per American Diabetes Association, in 2021, 38.4 million Americans, or 11.6% of the total population, had diabetes. 2 million Americans were with type 1 diabetes, including around 304,000 children and adolescents. Besides, 1.2 million Americans are diagnosed with diabetes every year. Obesity, bad diet, and sedentary behavior all contribute to the rising numbers. As a result, the demand for drugs like insulin, GLP-1 receptor agonists, and SGLT2 inhibitors is increasing. Furthermore, the need for monitoring equipment such as continuous glucose monitors (CGMs) and blood glucose meters is growing. This increase in demand is driving market innovation, with businesses spending in research and development activities to produce more effective and user-friendly devices that can help patients manage diabetes more effectively and enhance their quality of life.

Rising Healthcare Expenditure

The rising healthcare spending of the general population in the United States is a major driver of the diabetes care medications and devices industry. According to Centers for Medicare and Medicaid Services, the United States health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Retail prescription drug spending elevated by 8.4% to $405.9 Billion in 2022, above the 6.8% increase seen in 2021.  As people devote more resources to their health, there is a greater demand for complete diabetes care options. Patients with higher spending capacity have access to advanced diabetic care, including the most recent drugs and cutting-edge technologies like continuous glucose monitors (CGMs) and insulin pumps. This increased spending is also linked to a growing preference for individualized and preventive healthcare, which encourages the use of technology that improve diabetes control. With more resources available, patients are more likely to invest in high-quality, effective treatments and monitoring systems, driving the market for diabetes care medications and devices.

United States Diabetes Care Drugs and Devices Market News:

  • In June 2024, DexCom, Inc., the global pioneer in real-time continuous glucose monitoring for diabetics, announced that Dexcom G7 Continuous Glucose Monitoring (CGM) System is now immediately compatible with Apple Watch in the United States. Dexcom G7 is the first and only CGM that supports Direct to Apple Watch, giving customers the freedom and convenience of real-time glucose readings on their wrist even when their iPhone is not with them.
  • In May 2024, Tandem Diabetes Care, Inc. and Dexcom, Inc. have announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems. Tandem Mobi, the world's smallest, most durable automated insulin delivery (AID) system1, debuted in the United States earlier this year.

United States Diabetes Care Drugs and Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on offering and distribution channel.       

Offering Insights:

  • Devices
    • Monitoring Devices
      • Self-monitoring Blood Glucose Devices
      • Continuous Blood Glucose Monitoring
    • Management Devices
      • Insulin Pump
      • Insulin Syringes
      • Insulin Cartridges
      • Disposable Pens
  • Drugs
    • Oral Anti-Diabetes Drugs
    • Insulin Drugs
    • Combination Drugs
    • Non-Insulin Injectable Drugs
       

The report has provided a detailed breakup and analysis of the market based on the offering. This includes devices [monitoring devices (self-monitoring blood glucose devices and continuous blood glucose monitoring) and management devices (insulin pump, insulin syringes, insulin cartridges, and disposable pens)] and drugs (oral anti-diabetes drugs, insulin drugs, combination drugs, and non-insulin injectable drugs).

Distribution Channel Insights:

  • Online
  • Offline
     

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes online and offline.

Regional Insights:

  • Northeast
  • Midwest
  • South
  • West
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Diabetes Care Drugs and Devices Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units USD Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Offering
  • Distribution Channel
  • Region 
Offerings Covered
  • Devices: Monitoring Devices (Self-monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring), Management Devices (Insulin Pump, Insulin Syringes, Insulin Cartridges, Disposable Pens)
  • Drugs: Oral Anti-Diabetes Drugs, Insulin Drugs, Combination Drugs, Non-Insulin Injectable Drugs
Distribution Channels Covered Online, Offline
Regions Covered Northeast, Midwest, South, West
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the United States diabetes care drugs and devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the United States diabetes care drugs and devices market?
  • What is the breakup of the United States diabetes care drugs and devices market on the basis of offering?
  • What is the breakup of the United States diabetes care drugs and devices market on the basis of distribution channel?
  • What are the various stages in the value chain of the United States diabetes care drugs and devices market? 
  • What are the key driving factors and challenges in the United States diabetes care drugs and devices?
  • What is the structure of the United States diabetes care drugs and devices market and who are the key players?
  • What is the degree of competition in the United States diabetes care drugs and devices market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States diabetes care drugs and devices market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the United States diabetes care drugs and devices market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States diabetes care drugs and devices industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
United States Diabetes Care Drugs and Devices Market Report by Offering (Devices, Drugs), Distribution Channel (Online, Offline), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials